Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Open-market buy 10% owner bought 5,000 shares at $8.42 ($42,100)
  2. 4 Open-market buy 10% owner bought 11,500 shares at $8.51 ($97,865)
  3. 4 Open-market buy 10% owner bought 32,422 shares at $8.67 ($281,099)
  4. 4/A Open-market sale President and CEO sold 50,000 shares at an average $8.91 ($445,500)
  5. 4 Open-market buy 10% owner bought 10,447 shares at $8.70 ($90,889)
  6. 4 Open-market sale President and CEO sold 50,000 shares at an average $8.91 ($445,500)
  7. 4 Open-market sale Vice President and CFO sold 10,000 shares at $8.17 ($81,700)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale President and CEO sold 50,000 shares at an average $8.39 ($419,500)
  16. 4 Open-market buy 10% owner bought 8,000 shares at $8.03 ($64,240)
  17. 4 Open-market buy 10% owner bought 38,096 shares at $8.03 ($305,911)
  18. 4 Open-market sale Vice President and CFO sold 10,000 shares at $8.23 ($82,300)
  19. 4 Open-market buy Chief Financial Officer bought 4,658 shares at $4.43 ($20,635)
  20. 4 Open-market buy Chief Operating & Med. Officer bought 4,516 shares at $4.43 ($20,006)

Page 22 of 30 · 591 filings